問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Rehabilitation Medicine

更新時間:2023-09-19

潘信良PAN, SHIN-LIANG
  • Principal Investigator
  • Clinical Trial Experience (year) 7 years 9 個月

篩選

List

1Cases

2019-06-01 - 2021-04-12

Phase III

An Asian, Multicenter, Randomized, Double-blind, Placebo-controlled, 14-week Study of Mirogabalin in Participants With Central Neuropathic Pain Followed by a 52-week, Open-label Extension
  • Condition/Disease

    Central Neuropathic Pain

  • Test Drug

    DS-5565 (Mirogabalin)

Participate Sites
4Sites

Terminated4Sites